A61K 45 - Medicinal preparations containing active ingredients not provided for in groups

Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
12/2004
12/15/2004	EP1383515B1 Activation of natural killer cells by adenosine a3 receptor agonists
12/15/2004	EP1322301B1 Combination particles for the treatment of asthma
12/15/2004	EP1322300B1 Inhalation particles incorporating a combination of two or more active ingredients
12/15/2004	EP1294371B1 Medium chain fatty acids applicable as antimicrobial agents
12/15/2004	EP1263711B1 Novel use of phenylheteroalkylamine derivatives
12/15/2004	EP1259248B1 Methods for treating cancers expressing vascular endothelial growth factor d
12/15/2004	EP1218005B1 Vitronectin receptor antagonists
12/15/2004	EP1207899B1 Treatment of allergic rhinitis with certain vasoactive amine binding proteins
12/15/2004	EP1176963B1 Use of dopamine d 3 receptor antagonists for producing medicaments for treating kidney disorders
12/15/2004	EP1126841B1 Combinations of a 5ht1b/1d agonist and a selective cox-2 inhibitor for the treatment of migraine
12/15/2004	EP1015022B1 New improved formulation for treatment of thromboembolism
12/15/2004	EP0968290B1 Anti-alphavbeta3 humanized monoclonal antibodies
12/15/2004	CN1555374A Novel pyridine-substituted pyrazolopyridine derivatives
12/15/2004	CN1555372A Pyrane derivatives as both ace- and nep- inhibitors
12/15/2004	CN1555365A N-aminoimidazole derivative for inhibiting HIV
12/15/2004	CN1555268A Therapeutic agents comprising pro-apoptotic proteins
12/15/2004	CN1555266A Hormone replacement therapy
12/15/2004	CN1555265A Medical preparation for injection
12/15/2004	CN1555261A Drugs comprising combination of antithrombotic agent with pyrazolone derivative
12/15/2004	CN1555260A Aminoalkyl-substituted aromatic bicyclic compounds, methods for their preparation and their use as pharmaceuticals
12/15/2004	CN1555256A Pharmaceutical formulation comprising a proton pump inhibitor and antacids
12/15/2004	CN1555227A Enteral formulations
12/15/2004	CN1554748A Method for preparing megakaryocytic preparation by amplifying macronucleus ancestral cell and mature megacaryocyte and use
12/15/2004	CN1554444A Endothelial cell proliferation inhibitor and method of use
12/15/2004	CN1554351A Medicinal composite preparation including active vitamine d compound and its use
12/15/2004	CN1554343A Compounds for treating fibromyalgia and chronic fatigue syndrome
12/15/2004	CN1554341A Compounds for treating fibromyalgia and chronic fatigue syndrome
12/15/2004	CN1179972C Growth hormone secretagogues
12/15/2004	CN1179753C Contraceptive compositions containing antiprogesting and progestinic
12/15/2004	CN1179752C Benzodiazapine compounds containing imidazole propanamido and its preparing process and application
12/14/2004	US6831286 Method for determining a tilt angle of an optical pickup head
12/14/2004	US6831103 Composition comprising theanine
12/14/2004	US6831102 For treating or delaying progression or onset of obesity, hypercholesterolemia, atherosclerosis, depression, osteoporosis, hypothyroidism, non-toxic goiter, reduced bone mass, density or growth, eating disorders, cardiac arrhythmia
12/14/2004	US6831089 1,4-di-substituted piperidines, some of which have M2 selectivity even higher than that of 3-alpha-chloroimperialine for treating cognitive disorders such as Alzheimer's disease
12/14/2004	US6831073 Treating postmenopausal estrogenic deficiencies without appearance of osteoporosis and/or withdrawal bleeding; continuously administering free or esterified estradiol and nomegestrol acetate
12/14/2004	US6830882 For antiobesity/diabetes agents; drug screening
12/14/2004	US6830760 Glyburide composition
12/14/2004	US6830759 Antidiabetic preparation for oral administration
12/14/2004	US6830755 Method for relaxing human beings using personal care compositions
12/14/2004	CA2235038C Use of a tnf alpha antagonist for treating neurogenic skin redness
12/13/2004	CA2468651A1 Detection of neurodegenerative diseases
12/13/2004	CA2432358A1 Nutritional supplementation for treating deficiency states in bowel disease
12/09/2004	WO2004106411A2 Biodegradable poly(beta-amino esters) and uses thereof
12/09/2004	WO2004106378A2 Method of treating corneal transplant rejection by using vegf antagonists
12/09/2004	WO2004105798A1 A PHARMACEUTICAL COMPOSITION COMPRISING A P2X7-RECEPTOR ANTAGONIST AND A TUMOUR NECROSIS FACTOR α
12/09/2004	WO2004105797A1 A pharmaceutical composition comprising a p2x7 antagonist and sulfasalazine
12/09/2004	WO2004105796A1 A pharmaceutical composition containing a p2x7 receptor antagonist and methotrexate
12/09/2004	WO2004105795A1 Pharmaceutical combinations of a proton pump inhibitor and a compound which modifies gastrointestinal motility
12/09/2004	WO2004105777A1 Rock flour, especially dolomite-based medicament, for the treatment of cancer diseases
12/09/2004	WO2004105768A1 Composition comprising antiprogestins and pure antiestrogens for prophylaxis and treatment of hormone-dependent diseases
12/09/2004	WO2004105756A2 Combination comprising (a) a neuroprotecting agent and (b) an agent binding to gadph and pharmaceutical use thereof
12/09/2004	WO2004105747A1 Combination chemotherapy comprising capecitabine and a liposomal platinum complex
12/09/2004	WO2004105745A1 Aqueous olanexidine solution, method of preparing the same, and disinfectant
12/09/2004	WO2004105744A1 Use of iron for treating attention deficit hyperactivity disorder in children
12/09/2004	WO2004105741A1 Cosmetic and/or pharmaceutical compositions comprising dimthylsulphone for the cure and prevention of irritation, inflammation and cutaneous erythema
12/09/2004	WO2004105732A1 Combination chemotherapy comprising gemcitabine and a liposomal platinum complex
12/09/2004	WO2004105731A1 Nasal formulations including a topical decongestant and a topical corticosteroid and their use in treatment of obstructive sleep apnea
12/09/2004	WO2004105703A2 Compounds, formulations, and methods for treating or preventing rosacea
12/09/2004	WO2004105688A2 Bactericidal composition and associated method
12/09/2004	WO2004105682A2 Carbostyril derivatives and mood stabilizers for treating mood disorders
12/09/2004	WO2004091505A3 Bacteriophage for lysis of methylobacterium and compositions and uses thereof
12/09/2004	WO2004080446B1 Treatment of intestinal conditions with n-2,3,3-tetramethylbicyclo[2.2.1]heptan-2-amine
12/09/2004	WO2004080429A3 Use of thiol-based compositions in ameliorating mucosal injury
12/09/2004	WO2004080408A3 Method of treating cancer with azaspirane compositions
12/09/2004	WO2004078108A3 Fibrate tablet and method for the production thereof
12/09/2004	WO2004071413A3 Method and composition for potentiating an opiate analgesic
12/09/2004	WO2004045551A3 Pharmaceutical composition
12/09/2004	WO2004032863A3 Oral formulations for proteins and polypeptides
12/09/2004	WO2004032829A3 Immunostimulatory compositions and methods of stimulating an immune response
12/09/2004	WO2004028473A3 Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome
12/09/2004	WO2004026238A3 Immunotherapeutic compositions and methods for the treatment of moderately to well-differentiated cancers
12/09/2004	WO2004012503A3 Compositions comprising muscle progenitor cells and uses thereof
12/09/2004	WO2003097051A3 Use of compounds that are effective as selective opiate receptor modulators
12/09/2004	WO2003093478A9 Immunoconjugates for the treatment of tumours
12/09/2004	WO2003092468A3 Biomatrix structural containment and fixation systems and methods of use thereof
12/09/2004	WO2003090687A8 Using heat shock proteins to increase immune response
12/09/2004	WO2003080808A3 Novel compositions and methods in cancer
12/09/2004	WO2003080582A3 Fredericamycin derivatives
12/09/2004	WO2003062262A3 Modulation of heat-shock-protein-based immunotherapies
12/09/2004	WO2003053219A3 Methods for slowing senescence and treating and preventing diseases associated with senescence
12/09/2004	US20040250306 Transgenic rodent for use as tools in identifying modulator for treatment of diabetes, hypertension, cardiovascular and bone disorders
12/09/2004	US20040249317 Increasing retrievable cells from a breast duct
12/09/2004	US20040249132 Nuclear hormone receptor ligand binding domain
12/09/2004	US20040249123 Nuclear receptor for use in identifying modulator for diagnosis, prevention and treatment of cell proliferative, blood, cardiovascular, skin, inflammatory, bone and nervous system disorders
12/09/2004	US20040248992 Method and composition for inhibiting arteriosclerosis
12/09/2004	US20040248986 Treating aggressive breast cancer with tesmilifene hydrochloride; synergistic effect combine with other chemotherapeutic agent like doxorubicin, taxanes
12/09/2004	US20040248971 Treating prostate cancer; suppress the expression of prostate-specific antigen
12/09/2004	US20040248966 A drug contains melatonin, other melatonergic agents, melatonin agonists and melatonin antagonists, in an effective amount within the range of 0.0025 to 50 mg, and other therapeutic agent; improving the restorative quality of sleep; sustained release
12/09/2004	US20040248948 Combination therapy
12/09/2004	US20040248942 Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
12/09/2004	US20040248928 Cardiovascular system protection; ischemic attack, reperfusion, cardiac surgery
12/09/2004	US20040248915 Method for administration of troxacitabine
12/09/2004	US20040248914 Method for the treatment of overactive bladder
12/09/2004	US20040248909 Adenosine a1 receptor antagonist for treating hypoxia-induced learning memory impairment
12/09/2004	US20040248906 Use of c-src inhibitors alone or in combination with st1571 for the treatment of leukaemia
12/09/2004	US20040248891 Imidazotriazinone-containing compositions for nasal administration
12/09/2004	US20040248876 Reducing islet amyloid polypeptide (IAPP) associated deposit; type II diabetes
12/09/2004	US20040248874 Anti-microbial composition comprising a metal ion chelating agent
12/09/2004	US20040248871 Prevent cell differentiation
12/09/2004	US20040248867 Novel anti-inflammatory 17.alpha.-heterocyclic-esters of 17.beta.carbothioate androstane derivatives

1 ... 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 ... 1151